We are live on
!
Find out more
VP
Vitruvian Partners Portfolio holdings
AUM
$112M
1-Year Est. Return
2.02%
This Fund
S&P 500
This Quarter
Est. Return
-12.59%
1 Year Est. Return
+2.02%
3 Year Est. Return
+35.84%
5 Year Est. Return
+18.92%
10 Year Est. Return
–
AUM
$105M
AUM Growth
-$11.3M
(-9.8%)
Cap. Flow
+$8.09M
Cap. Flow
% of AUM
7.71%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
2
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Global E Online
GLBE
|
+$6.88M |
| 2 |
RxSight
RXST
|
+$2.57M |
| 3 |
Xometry
XMTR
|
+$2.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
API
Agora
API
|
+$3.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.31% |
| 2 | Consumer Discretionary | 31.04% |
| 3 | Healthcare | 18.69% |
| 4 | Industrials | 7.96% |
Similar funds
RTM
JE
GW
SPWM
OCA
APFP
FCU
DM
Vitruvian Partners's Q1 2025 Portfolio in Review
As of Q1 2025, Vitruvian Partners held 7 positions worth $105M, down 9.8% from $116M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Vitruvian Partners deployed $8.09M of net new capital in Q1 2025, opening 1 new position and adding to 2 existing holdings. Its largest new stake was Global E Online: 140,037 shares worth $4.99M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the most notable exit was Agora, an estimated $3.51M sold.
- Vitruvian Partners's largest Q1 2025 buy was Global E Online: 140,037 shares worth $4.99M.
- Vitruvian Partners added most to RxSight in Q1 2025, an estimated $2.57M increase.
- Vitruvian Partners fully exited Agora in Q1 2025, selling an estimated $3.51M.
- Vitruvian Partners's ten largest holdings make up 100% of its $105M portfolio in Q1 2025.
- Vitruvian Partners opened 1 new position and closed 1 in Q1 2025.
- Vitruvian Partners's portfolio value fell 9.8% quarter-over-quarter to $105M.
Based on Vitruvian Partners's 13F filing for Q1 2025, filed 8 May 2025.